Cargando…

Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease

Polypharmacy is common in patients with nonalcoholic fatty liver disease (NAFLD) and previous reports suggest that NAFLD is associated with altered drug disposition. This study aims to determine if patients with NAFLD are at risk for altered drug response by characterizing changes in hepatic mRNA ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Powell, Nicholas R., Liang, Tiebing, Ipe, Joseph, Cao, Sha, Skaar, Todd C., Desta, Zeruesenay, Qian, Hui-Rong, Ebert, Philip J., Chen, Yu, Thomas, Melissa K., Chalasani, Naga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020163/ https://www.ncbi.nlm.nih.gov/pubmed/36927865 http://dx.doi.org/10.1038/s41467-023-37209-1

Ejemplares similares

Quantification of spatial pharmacogene expression heterogeneity in breast tumors
por: Powell, Nicholas R., et al.
Publicado: (2022)

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
por: Masuoka, Howard C, et al.
Publicado: (2013)

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)

Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform
por: Kim, Byungwook, et al.
Publicado: (2021)

Genetic diversity of ‘Very Important Pharmacogenes’ in two South-Asian populations
por: Bharti, Neeraj, et al.
Publicado: (2021)

Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease
por: Yates, Katherine P., et al.
Publicado: (2017)

Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype-dependent
por: Michaud, Veronique, et al.
Publicado: (2013)

Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis
por: Noureddin, Mazen, et al.
Publicado: (2023)

Pharmacogene regulatory elements: from discovery to applications
por: Smith, Robin P, et al.
Publicado: (2012)

Identification, conservation, and expression of tiered pharmacogenes in zebrafish
por: Demery-Poulos, Catherine, et al.
Publicado: (2022)

Genetic Variation among Pharmacogenes in the Sardinian Population
por: Idda, Maria Laura, et al.
Publicado: (2022)

Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China
por: Wang, Yuliang, et al.
Publicado: (2021)

Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials
por: Athinarayanan, Shaminie, et al.
Publicado: (2014)

Rifampin modulation of xeno‐ and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes
por: Gufford, Brandon T., et al.
Publicado: (2018)

Dynamic Alterations to Hepatic MicroRNA-29a in Response to Long-Term High-Fat Diet and EtOH Feeding
por: Liang, Tiebing, et al.
Publicado: (2023)

Ontogeny-related pharmacogene changes in the pediatric liver transcriptome
por: Meier, Richard, et al.
Publicado: (2018)

Pharmacogene Variation Consortium Gene Introduction: NUDT15
por: Yang, Jun J., et al.
Publicado: (2018)

Sex-Biased Expression of Pharmacogenes across Human Tissues
por: Idda, Maria Laura, et al.
Publicado: (2021)

Comprehensive characterization of pharmacogenes in a Taiwanese Han population
por: Lu, Hsing-Fang, et al.
Publicado: (2022)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Learning from biomedical linked data to suggest valid pharmacogenes
por: Dalleau, Kevin, et al.
Publicado: (2017)

Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes
por: Caspar, Sylvan M., et al.
Publicado: (2020)

Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
por: Tilleman, Laurentijn, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation
por: Brunt, Elizabeth M.
Publicado: (2016)

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
por: Kitabatake, Hiroyuki, et al.
Publicado: (2017)

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022)

Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes
por: Benson, Eric A., et al.
Publicado: (2016)

Importance of Variables in Nonalcoholic Fatty Liver Disease Patients
por: Garg, Vivek Kumar, et al.
Publicado: (2018)

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans
por: Liu, Wanqing, et al.
Publicado: (2016)

Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines
por: Chhibber, A, et al.
Publicado: (2017)

Calling Star Alleles With Stargazer in 28 Pharmacogenes With Whole Genome Sequences
por: Lee, Seung‐been, et al.
Publicado: (2019)

Combination of Genome-Wide Polymorphisms and Copy Number Variations of Pharmacogenes in Koreans
por: Han, Nayoung, et al.
Publicado: (2021)

Genetic landscape of 125 pharmacogenes in Chinese from the Chinese Millionome Database
por: Qi, Guangzhao, et al.
Publicado: (2021)

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes
por: Fracowiak, Jochen, et al.
Publicado: (2022)

Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
por: Chen, Yuanhuang, et al.
Publicado: (2021)

Gallstone Disease Does Not Predict Liver Histology in Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2014)

Association between cytokines and liver histology in children with nonalcoholic fatty liver disease
por: Perito, Emily R., et al.
Publicado: (2017)

Effects of Phlebotomy on Liver Enzymes and Histology of Patients with Nonalcoholic Fatty Liver Disease
por: Khodadoostan, Mahsa, et al.
Publicado: (2017)

Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease
por: Sonmez, Alper, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ildmqpucvbtdicb1ig5jo0vm1a